Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
NCT03041792
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Liraglutide
OTHER:
Placebo
Sponsor
Pfizer